References
- Current status of non-communicable disease in the Republic of Korea. http://www.cdc.go.kr/board/board.es?mid=a20602010000&bid=0034&list_no=711878&act=view#. Updated 2021. Accessed September 8, 2022.
- Dahlof B. Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 2010;105(1 Suppl):3A-9A.
- Knutsson A. Methodological aspects of shift-work research. Chronobiol Int 2004;21(6):1037-47.
- Costa G. Shift work and occupational medicine: an overview. Occup Med (Lond) 2003;53(2):83-8.
- Rosa RR, Colligan M. Plain Language About Shiftwork. Washington, D.C., USA: U.S. Department of Health and Human Services; 1997.
- Boggild H, Knutsson A. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health 1999;25(2):85-99.
- Torquati L, Mielke GI, Brown WJ, Kolbe-Alexander T. Shift work and the risk of cardiovascular disease. A systematic review and meta-analysis including dose-response relationship. Scand J Work Environ Health 2018;44(3):229-38.
- Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008;83(11):1203-12.
- Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325(7374):1202.
- Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 2006;333(7578):1114-7.
- Kang D, Kang SK, Choi WJ, Lee SH, Lee JH, Kwak K. Association between shift work and hyperhomocysteinemia in male workers. Ann Occup Environ Med 2019;31(1):e1.
- Moon HW, Whang DH, Ko YJ, Joo SY, Yun YM, Hur M, et al. Reference interval and determinants of the serum homocysteine level in a Korean population. J Clin Lab Anal 2011;25(5):317-23.
- Masip J, Germa Lluch JR. Alcohol, health and cardiovascular disease. Rev Clin Esp (Barc) 2021;221(6):359-68.
- Banks E, Joshy G, Korda RJ, Stavreski B, Soga K, Egger S, et al. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC Med 2019;17(1):128.
- Myers J. Cardiology patient pages. Exercise and cardiovascular health. Circulation 2003;107(1):e2-5.
- Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med 2009;60(1):39-54.
- Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42(4):630-6.
- Brandao MP, Pimentel FL, Cardoso MF. Serum homocysteine concentrations in Portuguese young adults reference interval. Acta Med Port 2011;24(2):271-8.
- Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268(7):877-81.
- Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337(4):230-6.
- Dhindsa DS, Khambhati J, Schultz WM, Tahhan AS, Quyyumi AA. Marital status and outcomes in patients with cardiovascular disease. Trends Cardiovasc Med 2020;30(4):215-20.
- Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health 1992;82(6):816-20.
- Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43(10):1731-7.
- Lanier JB, Bury DC, Richardson SW. Diet and physical activity for cardiovascular disease prevention. Am Fam Physician 2016.93(11):919-24.
- North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res 2012;110(8):1097-108.
- Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol 2016;594(8):2061-73.
- Martins PJ, D'Almeida V, Vergani N, Perez AB, Tufik S. Increased plasma homocysteine levels in shift working bus drivers. Occup Environ Med 2003;60(9):662-6.
- Zhang S, Wang Y, Li Q, Wang Z, Wang H, Xue C, et al. Different exposure metrics of rotating night shift work and hyperhomocysteinaemia among Chinese steelworkers: a cross-sectional study. BMJ Open 2020;10(12):e041576.
- Copertaro A, Bracci M, Barbaresi M. Assessment of plasma homocysteine levels in shift healthcare workers. Monaldi Arch Chest Dis 2008;70(1):24-8.
- Karolczak K, Olas B. Mechanism of action of homocysteine and its thiolactone in hemostasis system. Physiol Res 2009;58(5):623-33.
- Lentz SR, Piegors DJ, Fernandez JA, Erger RA, Arning E, Malinow MR, et al. Effect of hyperhomocysteinemia on protein C activation and activity. Blood 2002;100(6):2108-12.
- Toroser D, Sohal RS. Age-associated perturbations in glutathione synthesis in mouse liver. Biochem J 2007;405(3):583-9.
- Zhang D, Chen Y, Xie X, Liu J, Wang Q, Kong W, et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. J Mol Cell Cardiol 2012;53(4):487-96.
- Zhao J, Chen H, Liu N, Chen J, Gu Y, Chen J, et al. Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of atherosclerosis. J Stroke Cerebrovasc Dis 2017;26(12):2695-9.
- Puttonen S, Harma M, Hublin C. Shift work and cardiovascular disease - pathways from circadian stress to morbidity. Scand J Work Environ Health 2010;36(2):96-108.
- Aisbett B, Condo D, Zacharewicz E, Lamon S. The impact of shiftwork on skeletal muscle health. Nutrients 2017;9(3):248.
- Ostrakhovitch EA, Tabibzadeh S. Homocysteine in chronic kidney disease. Adv Clin Chem 2015;72:77-106.
- Karmin O , Siow YL. Metabolic imbalance of homocysteine and hydrogen sulfide in kidney disease. Curr Med Chem 2018;25(3):367-77.